These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17416532)

  • 21. Recent advances in prodrugs as drug delivery systems.
    Lin C; Sunkara G; Cannon JB; Ranade V
    Am J Ther; 2012 Jan; 19(1):33-43. PubMed ID: 21150770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-immolative anthracycline prodrugs for suicide gene therapy.
    Niculescu-Duvaz I; Niculescu-Duvaz D; Friedlos F; Spooner R; Martin J; Marais R; Springer CJ
    J Med Chem; 1999 Jul; 42(13):2485-9. PubMed ID: 10395490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
    Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
    Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prodrug strategies in anticancer chemotherapy.
    Kratz F; Müller IA; Ryppa C; Warnecke A
    ChemMedChem; 2008 Jan; 3(1):20-53. PubMed ID: 17963208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amplified release through the stimulus triggered degradation of self-immolative oligomers, dendrimers, and linear polymers.
    Wong AD; DeWit MA; Gillies ER
    Adv Drug Deliv Rev; 2012 Aug; 64(11):1031-45. PubMed ID: 21996055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing SN38 prodrug delivery using a self-immolative linker and endogenous albumin transport.
    Jiang X; Zhu L; Wei Q; Lu W; Yu J; Zhu S
    J Control Release; 2024 May; 369():622-629. PubMed ID: 38604383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a new enzyme-responsive self-immolative spacer conjugate applicable to the controlled drug release.
    Jin HJ; Lu J; Wu X
    Bioorg Med Chem; 2012 Jun; 20(11):3465-9. PubMed ID: 22564382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-immolative nitrogen mustards prodrugs cleavable by carboxypeptidase G2 (CPG2) showing large cytotoxicity differentials in GDEPT.
    Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Lehouritis P; Marais R; Springer CJ
    J Med Chem; 2003 Apr; 46(9):1690-705. PubMed ID: 12699387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymeric prodrugs.
    Azori M
    Crit Rev Ther Drug Carrier Syst; 1987; 4(1):39-65. PubMed ID: 3315236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and preliminary evaluation in vitro of novel naproxen-dendritic peptide conjugates.
    Ouyang L; Zhang J; Pan J; Yan L; Guo L
    Drug Deliv; 2009 Aug; 16(6):348-56. PubMed ID: 19606949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Water-soluble dendritic core-shell-type architectures based on polyglycerol for solubilization of hydrophobic drugs.
    Türk H; Shukla A; Alves Rodrigues PC; Rehage H; Haag R
    Chemistry; 2007; 13(15):4187-96. PubMed ID: 17310496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prodrugs: design and clinical applications.
    Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
    Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug targeting using conjugates: the importance of pharmaceutical chemistry.
    Byrn SR; Stowell JG
    J Drug Target; 1995; 3(4):239-41. PubMed ID: 8820996
    [No Abstract]   [Full Text] [Related]  

  • 34. Modulating paclitaxel bioavailability for targeting prostate cancer.
    Kumar SK; Williams SA; Isaacs JT; Denmeade SR; Khan SR
    Bioorg Med Chem; 2007 Jul; 15(14):4973-84. PubMed ID: 17502149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Research of oral prodrugs: opportunities and challenges].
    Cao F; Ping QN; Chen J
    Yao Xue Xue Bao; 2008 Apr; 43(4):343-9. PubMed ID: 18664193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In situ cross-linkable high molecular weight hyaluronan-bisphosphonate conjugate for localized delivery and cell-specific targeting: a hydrogel linked prodrug approach.
    Varghese OP; Sun W; Hilborn J; Ossipov DA
    J Am Chem Soc; 2009 Jul; 131(25):8781-3. PubMed ID: 19499915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-directed enzyme prodrug therapy: a promising approach for a selective treatment of cancer based on prodrugs and monoclonal antibodies.
    Tietze LF; Krewer B
    Chem Biol Drug Des; 2009 Sep; 74(3):205-11. PubMed ID: 19660031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic supermolecules--towards controllable nanomaterials.
    Smith DK
    Chem Commun (Camb); 2006 Jan; (1):34-44. PubMed ID: 16353086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphate-Based Self-Immolative Linkers for the Delivery of Amine-Containing Drugs.
    Đud M; Tichotová M; Procházková E; Baszczyňski O
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pyridinone-methide elimination.
    Perry-Feigenbaum R; Baran PS; Shabat D
    Org Biomol Chem; 2009 Dec; 7(23):4825-8. PubMed ID: 19907770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.